Yongjian U. Zhou - Publications

Timing of Adjuvant Imatinib Initiation and Recurrence-Free Survival After Curative Resection for Intermediate- and High-Risk Gastrointestinal Stromal Tumors: A Multicenter Real-World Cohort Study.

Journal: International journal of cancer

Published: June 02, 2026

Prognostic inflammatory-immune score-based risk stratification optimizes adjuvant therapy for non-gastric gastrointestinal stromal tumors: a multicenter study.

Journal: Frontiers in immunology

Published: April 03, 2026

Laparoscopic versus open surgery for locally advanced gastric gastrointestinal stromal tumors following neoadjuvant imatinib therapy: a multicenter propensity-weighted cohort study.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: February 23, 2026

Study on risk stratification and treatment strategy of blood indicators in patients with moderate risk of GIST.

Journal: Frontiers in oncology

Published: November 08, 2025

The predictive value of the systemic inflammation-nutrition index for treatment response and prognosis in patients with locally advanced gastrointestinal stromal tumors receiving neoadjuvant imatinib therapy: a dual-center retrospective cohort study.

Journal: Therapeutic advances in medical oncology

Published: June 10, 2025

A novel prognostic system for locally advanced gastrointestinal stromal tumors after neoadjuvant imatinib therapy based on the metro-ticket paradigm: a retrospective dual-center study.

Journal: Surgical endoscopy

Published: May 14, 2025

Monitoring the plasma concentration of ripretinib and its metabolites in Chinese patients with gastrointestinal stromal tumors in a real-life setting.

Journal: Cancer

Published: May 06, 2025

Long-term outcomes of ripretinib versus sunitinib in Chinese patients with advanced gastrointestinal stromal tumor: An updated analysis of a phase 2 randomized clinical trial.

Journal: Cancer

Published: April 25, 2025

Expression, Prognostic Value, and Biological Function of CENPM in Colon Adenocarcinoma.

Journal: Current medicinal chemistry

Published: February 15, 2025

Tumor necrosis, an independent prognostic factor for predicting gastric gastrointestinal stromal tumors.

Journal: Journal of gastrointestinal oncology

Published: February 09, 2025

Radiomics models with baseline MRI and clinical data to predict target therapy response and high-risk mortality in metastatic GIST.

Journal: Scientific reports

Published: January 31, 2025

Treatment research after failure of fourth-line standard therapy for advanced gastrointestinal stromal tumors: A review.

Journal: Cancer

Published: January 29, 2025